Flexible delivery of opioid agonist treatment during COVID-19 in Norway: qualitative and quantitative findings from an online survey of provider experiences.  McDonald R, Bech AB, Clausen T.  BMC Health Serv Res. 2023 Sep 7;23(1):965. doi…

Trends in Opioid Medication Adherence During the COVID-19 Pandemic: Retrospective Cohort Study.  Marashi A, Warren D, Call G, Dras M.  JMIR Public Health Surveill. 2023 Sep 1;9:e42495. doi: 10.2196/42495. PMID: 37656492; PMCID: PMC10504620…

Early COVID-Related pandemic impacts and subsequent opioid outcomes among persons receiving medication for opioid use disorder: a secondary data analysis of a Type-3 hybrid trial.  Janssen T, Garner BR, Yermash J, Yap KR, Becker SJ.  Addic…

Implementation and Outcome Evaluation of LA DOOR: A Proposition 47-Funded Program in Los Angeles: Cohort 2 Final Evaluation Report.  Labriola MM, Sobol D, Sims H, Holliday SB.  Rand Health Q. 2023 Sep 15;10(4):4. PMID: 37720070; PMCID: PMC…

Clinician Perspectives on Delivering Medication Treatment for Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Evaluation.  Lott AM, Danner AN, Malte CA, Williams EC, Gordon AJ, Halvorson MA, Saxon AJ, Hagedorn HJ, Sayre GG, Hawk…

What can we learn from COVID-19 to improve opioid treatment? Expert providers respond.  Harris LM, Marsh JC, Khachikian T, Serrett V, Kong Y, Guerrero EG.  J Subst Use Addict Treat. 2023 Aug 29;154:209157. doi: 10.1016/j.josat.2023.209157…